AzurRx BioPharma, Inc.
USD3.45
+0.07 (+2.07%)
CEO
James Sapirstein
IPO Date
2016-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.38
Prev. Close
$3.38
Day Low
$3.38
Day High
$3.66
52W Low
$2.68
52W High
$26.30
Market Cap
$0.00B
Volume
0.63M
| -0.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 1237.2% | -328615.3% | 0.00 | 0.51 | -1.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -328.7% | -170.5% | 0.35 | 0.80 | -1.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -302.5% | -181.2% | 0.06 | 1.60 | -1.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -668.2% | -202.5% | 0.25 | 0.79 | -3.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -454.1% | -216.0% | 0.05 | 1.27 | -3.2 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | 163.4% | -88.7% | -1.81 | 0.23 | -8.1 |
| -0.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -4.1% | -0.9% | 0.03 | 2.62 | -1.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 15.9% | -1.2% | -0.13 | 2.81 | -4.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 24.1% | -1.5% | -0.16 | 2.90 | -3.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -814.5% | 37.0% | -0.04 | 3.03 | 0.1 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -131.9% | -67.4% | 0.08 | 1.33 | -1.2 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -53.4% | -42.7% | 0.03 | 3.68 | -2.4 |
| 31 Dec 2020 | Q4 | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.51 | 0.0 |
| 30 Sept 2020 | Q3 | 0.0% | 0.0% | -0.0% | -0.0% | 0.01 | 4.39 | -937.2 |